New compounds may aid in development of targeted therapies for a rare paediatric cancer

Yes

Two recently discovered compounds have shown promise in preclinical studies for treating Ewing sarcoma, a rare cancer that predominantly affects children and adolescents.

No relation
No
01/04/2016 2:12 pm
There are no related objects.